CD177 and breast carcinoma: Integrins are cell surface receptors that mediates interactions between cells and surrounding ECM (45), and they were able to modulate cell cycle progression and cell proliferation via chk1 and Rb/E2F pathways and were also regulated by E2 in breast cancer cells (50, 51).